Shelley Ackerman

Company: Bolt Biotherapeutics

Job title: Senior Director

Seminars:

Boltbody Immune-stimulating Antibody Conjugates: A New Class of Immuno-oncology Therapeutics 12:00 pm

Immune Stimulating Antibody Conjugates (ISACs) provide unexpected biological advantages over the mixture of antibody and small molecule TLR7/8 agonist Treatment with ISACs elicits durable anti-tumor immunity and T cell-dependent immunological memory Next generation ISACs enable targeting of tumors with lower antigen expressionRead more

day: Conference Day 2